The first pig heart to be transplanted into a human is moved from a perfusion transport system to the patient during the groundbreaking procedure January 7, 2022. This is the first human to receive a pig heart transplant. #Pigheart

January 10, 2022 — The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) announced today the first successful transplant of a genetically modified pig’s heart into a human patient. The heart transplant patient, a 57-year-old Maryland man, is doing well following the groundbreaking cardiovascular surgery on Friday, Jan. 7 to save his life.

January 10, 2022 – Akura Medical Inc., a Shifamed portfolio company, announced the closing of its $25 million Series A1 financing, which will be used to support the development of its next-generation thrombectomy device. The financing was led by Cormorant Asset Management, with participation from The Capital Partnership (TCP), PA MedTech VC Fund and Shifamed angel investors.

January 10, 2022 — Cardiovascular Systems Inc. (CSI) is recalling the Wirion atherectomy embolic protection device system due to complaints of filter breakage during retrieval. Under certain circumstances, such as when the filter basket is too full, the filter assembly may become difficult to withdraw. In this situation, withdrawal may cause the Wirion system filter component to tear or separate, which may result in series adverse events such as embolization or the need for additional medical procedures.

January 7, 2022 — Abbott announced it is developing a new category of consumer biowearables called Lingo, which is being designed to track key signals in the body such as glucose, ketones, and lactate to help people better understand their general health and take action.

January 7, 2022 — Khaldoun Tarakji, M.D., M.P.H., associate section head of cardiac electrophysiology at the Heart, Vascular, and Thoracic Institute at Cleveland Clinic, has joined Medtronic as the vice president and chief medical officer (CMO) of the Cardiac Ablation Solutions (CAS) Operating Unit at Medtronic.

Houston Heart Failure Summit 2022

Course Directors are Arvind Bhimaraj, MD, MPH, and Ashrith Guha, MD, MPH

January 5, 2022 – A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted life years (QALY).

The study is published in the December 2021 issue of the Journal of Vascular Surgery.[1]

January 5, 2022 — The Feinstein Institutes for Medical Research, the science arm of Northwell Health, recently received a $150,000 grant from TD Bank, America's Most Convenient Bank, to launch a new research program and the first clinical trial to reduce cardiovascular disease (CVD) in the black community and determine the best behavioral interventions to lower cardiovascular disease.

January 5, 2022 — Stereotaxis announced a recent publication in Frontiers in Cardiovascular Medicine titled “Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism. This multi-center, prospective study evaluated 166 patients with paroxysmal or persistent atrial fibrillation (AF) who underwent pulmonary vein isolation using either Stereotaxis’ Robotic Magnetic Navigation (RMN) technology or manual contact force ablation catheters.

January 4, 2022 - Pie Medical Imaging (PMI), a global leader in cardiac imaging, part of the Esaote Group, recently announced the beginning of FASTIII, a multicenter randomized clinical trial investigating the use of angiography-based vessel fractional flow reserve (CAAS vFFR) in patients undergoing coronary revascularization procedures.  

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now